v3.26.1
Note 8 - Stock-based Compensation
6 Months Ended
Jul. 31, 2026
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

Note 8 - Stock-based compensation 

 

The Company's 2024 Omnibus Stock Incentive Plan, dated May 28, 2024 ("2024 Plan"), was approved by the Company's stockholders in July 2024. The 2024 Plan will expire in July 2027. The 2024 Plan authorizes awards to officers, employees, consultants, and independent directors. The 2024 Plan provides for the grant of deferred shares, non-qualified stock options, incentive stock options, restricted shares, restricted stock units, and performance-based restricted stock units intended to qualify under section 422 of the Internal Revenue Code. Grants were made in connection with the 2024 Plan to employees, officers, and independent directors, as further described below.   

 

Stock-based compensation expense

 

The Company has granted stock-based compensation awards to eligible employees, officers and independent directors. The Company recognized the following stock-based compensation expense for the periods presented:

 

  

Three Months Ended July 31,

  

Six Months Ended July 31,

 
  

2026

  

2025

  

2026

  

2025

 

Restricted stock-based compensation expense

 $232  $1,468  $413  $1,692 

Total stock-based compensation expense

 $232  $1,468  $413  $1,692 

 

Restricted stock

 

The following table summarizes the Company's restricted stock activity for the six months ended  July 31, 2026:

 

  

Restricted Shares

  

Weighted Average Price (Per share)

  

Aggregate Intrinsic Value

 

Outstanding at January 31, 2026

  160  $19.22  $3,069 

Granted

  59   27.15     

Vested and issued

  (74)        

Forfeited or retired

  (17)        

Outstanding at July 31, 2026

  128  $23.25  $2,977 

 

As of July 31, 2026, there was $2.6 million of unrecognized compensation expense related to unvested restricted stock granted under the 2024 Plan and previous plans. These costs are expected to be recognized over a weighted average period of 2.3 years.